Shashi Amur, Ph.D.

Scientific Adviser, Office of Translational Sciences
U.S. Food and Drug Administration
Biography Shashi Amur has expertise in the area of disease biomarkers, biomarkers in drug development and pharmacogenomics. Dr. Amur joined FDA as a Senior Genomics Reviewer in the Office of Clinical Pharmacology (OCP) in 2005, served as the Scientific Lead, Biomarker Qualification Program from 2012-2017in the Office of Translational Sciences (OTS) and is currently is a Scientific Advisor in OTS, CDER, FDA. Prior to joining FDA, she was the Associate Director of Assay Development at Neotropix, Inc. and Immune Tolerance Network. Dr. Amur received her Ph.D. in Biochemistry from Indian Institute of Science, India and completed post-doctoral fellowship at Temple University and at University of California at Los Angeles, in neurobiology and neuromolecular biology. She then joined Specialty Laboratories in Santa Monica, CA as a Research Scientist in the molecular biology division. Following this, Dr. Amur was a Senior Scientist at Applied Biosystems and gained expertise in application of DNA sequencing and PCR technologies. Email:
None yet.